Bank of America Lowers Vaxcyte (NASDAQ:PCVX) Price Target to $137.00
Vaxcyte (NASDAQ:PCVX – Get Free Report) had its price target reduced by research analysts at Bank of America from $157.00 to $137.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s price objective would suggest a potential upside of 306.65% from the […]
Vaxcyte (NASDAQ:PCVX – Get Free Report) had its price target reduced by research analysts at Bank of America from $157.00 to $137.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s price objective would suggest a potential upside of 306.65% from the […]
